Concepedia

Camila Manrique‐Acevedo

CM

Statistics

Publications

34

Citations

1.2K

H-Index

19

Active since

2017

Affiliations

University of Missouri(Current)

Harry S. Truman Memorial Veterans' Hospital

University of Missouri Health System

University of Saskatchewan

Mayo Clinic

Camila Manrique‐Acevedo is an author at University of Missouri specializing in physiology, life sciences, and endothelial dysfunction.

ORCID

Publications per year

2017–2024

34

Publications

34

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury

Annayya R. Aroor, Nitin A. Das, Andrea J. Carpenter et al. · Cardiovascular Diabetology · 2018 · 178 citations · Full text

, , +17

Fatty Acid Synthase Inhibitor TVB‐2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities

Majid Mufaqam Syed‐Abdul, Elizabeth J. Parks, Ayman H. Gaballah et al. · Hepatology · 2019 · 124 citations

, , +17

Endothelial Glycocalyx

Christopher Foote, Rogério N. Soares, Francisco I. Ramirez‐Perez et al. · Comprehensive physiology · 2022 · 124 citations · Full text

, , +17

Endothelial Glycocalyx

Christopher Foote, Rogério N. Soares, Francisco I. Ramirez‐Perez et al. · Comprehensive physiology · 2022 · 62 citations

, , +17

The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat

Javad Habibi, Annayya R. Aroor, Nitin A. Das et al. · Cardiovascular Diabetology · 2019 · 60 citations · Full text

, , +17

1–5 of 34